Since beginning with 4Life’s Research and Development department in 2000, Chief Scientific Officer Calvin McCausland, Ph.D. has conducted numerous clinical trials for 4Life Transfer Factor products and furthered transfer factor technology by leaps and bounds.

​

4Life’s Health Sciences Advisory Board (HSAB) is a team of renowned medical doctors, naturopaths, immunologists, and microbiologists from around the world. The team’s expertise influences research, guides new product development, and provides a wealth of knowledge to distributors at 4Life meetings and events.



With over $50 million in dedicated research, the public can now benefit from the cumulative knowledge of thousands of scientific papers on the workings of transfer factors.

​

In 2003, The American Medical Review reported on transfer factor technology. The broadcast aired on public television.